These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31437485)

  • 1. Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohort.
    Link RW; Mele AR; Antell GC; Pirrone V; Zhong W; Kercher K; Passic S; Szep Z; Malone K; Jacobson JM; Dampier W; Wigdahl B; Nonnemacher MR
    Virus Res; 2019 Oct; 272():197727. PubMed ID: 31437485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic attributes of blood-derived subtype-C HIV-1 tat and env in India and neurocognitive function.
    Tilghman MW; Bhattacharya J; Deshpande S; Ghate M; Espitia S; Grant I; Marcotte TD; Smith D; Mehendale S
    J Med Virol; 2014 Jan; 86(1):88-96. PubMed ID: 24150902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of subtype B HIV-1 tat in the Netherlands during 1985-2012.
    van der Kuyl AC; Vink M; Zorgdrager F; Bakker M; Wymant C; Hall M; Gall A; Blanquart F; Berkhout B; Fraser C; Cornelissen M;
    Virus Res; 2018 May; 250():51-64. PubMed ID: 29654800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
    Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.
    Rossenkhan R; MacLeod IJ; Sebunya TK; Castro-Nallar E; McLane MF; Musonda R; Gashe BA; Novitsky V; Essex M
    J Virol; 2013 May; 87(10):5732-45. PubMed ID: 23487450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus-1 Tat protein: immunological facets of a transcriptional activator.
    Gupta S; Mitra D
    Indian J Biochem Biophys; 2007 Oct; 44(5):269-75. PubMed ID: 18341200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia.
    Cowley D; Gray LR; Wesselingh SL; Gorry PR; Churchill MJ
    J Neurovirol; 2011 Feb; 17(1):70-81. PubMed ID: 21165788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND.
    Marino J; Maubert ME; Mele AR; Spector C; Wigdahl B; Nonnemacher MR
    Cell Mol Life Sci; 2020 Dec; 77(24):5079-5099. PubMed ID: 32577796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of HIV-1 transcription by Tat in cells derived from the CNS: evidence for the participation of NF-kappa B--a review.
    Taylor JP; Khalili K
    Adv Neuroimmunol; 1994; 4(3):291-303. PubMed ID: 7874398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 subtype C exhibits higher transactivation activity of Tat than subtypes B and E.
    Kurosu T; Mukai T; Komoto S; Ibrahim MS; Li YG; Kobayashi T; Tsuji S; Ikuta K
    Microbiol Immunol; 2002; 46(11):787-99. PubMed ID: 12516777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H; He J; Fong S; Wilcox G; Wood C
    J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer.
    Rizzi C; Alfano M; Bugatti A; Camozzi M; Poli G; Rusnati M
    Eur J Immunol; 2004 Feb; 34(2):530-6. PubMed ID: 14768058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intersubtype Genetic Variation of HIV-1 Tat Exon 1.
    Roy CN; Khandaker I; Oshitani H
    AIDS Res Hum Retroviruses; 2015 Jun; 31(6):641-8. PubMed ID: 25748226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation.
    Boven LA; Noorbakhsh F; Bouma G; van der Zee R; Vargas DL; Pardo C; McArthur JC; Nottet HS; Power C
    J Neurovirol; 2007 Apr; 13(2):173-84. PubMed ID: 17505986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of tat gene and long terminal repeat region of human immunodeficiency virus type-1 detected among the injecting drug users (IDUs) of Manipur, India: identification of BC recombinants.
    Mullick R; Sengupta S; Sarkar K; Chakrabarti S
    Virus Res; 2010 Feb; 147(2):195-201. PubMed ID: 19896991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
    Chande AG; Baba M; Mukhopadhyaya R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
    Popik W; Pitha PM
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9573-7. PubMed ID: 1719535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.